| Titolo |
Pubblicato in |
Anno |
| Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients |
TRANSFUSION MEDICINE |
2024 |
| Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity |
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
2024 |
| Ttv and cmv viral load dynamics. Which emerges first during immunosuppression |
JOURNAL OF MEDICAL VIROLOGY |
2024 |
| Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study |
ANTIBIOTICS |
2024 |
| Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study |
INFECTION AND DRUG RESISTANCE |
2023 |
| Case Report: Infectious prophylaxis in hematological malignancies |
FRONTIERS IN ONCOLOGY |
2023 |
| Multiplicity of blaKPC genes and pKpQIL plasmid plasticity in the development of ceftazidime-avibactam and Meropenem coresistance in Klebsiella pneumoniae sequence type 307 |
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
2023 |
| Editorial: HBV and lymphoma |
FRONTIERS IN ONCOLOGY |
2023 |
| High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy |
ANNALS OF HEMATOLOGY |
2023 |
| Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study |
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
2023 |
| Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study |
HEMATOLOGICAL ONCOLOGY |
2022 |
| Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience |
HAEMATOLOGICA |
2022 |
| Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study |
BLOOD |
2022 |
| Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL) |
LEUKEMIA |
2021 |
| Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” |
ANNALS OF HEMATOLOGY |
2021 |
| Regarding “Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era” |
THE ONCOLOGIST |
2021 |
| Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae |
BMC INFECTIOUS DISEASES |
2021 |
| Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura |
PEDIATRIC BLOOD & CANCER |
2021 |
| Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic |
JAC-ANTIMICROBIAL RESISTANCE |
2021 |
| Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib |
CANCERS |
2021 |
